These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29911355)

  • 1. Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity.
    Yin Y; Cai Z; Zhou XH
    Biom J; 2018 Sep; 60(5):879-892. PubMed ID: 29911355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative monotonicity assumptions for improving bounds on natural direct effects.
    Chiba Y; Taguri M
    Int J Biostat; 2013 Jul; 9(2):235-49. PubMed ID: 23893690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bounds on controlled direct effects under monotonic assumptions about mediators and confounders.
    Chiba Y
    Biom J; 2010 Oct; 52(5):628-37. PubMed ID: 20886528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using survival information in truncation by death problems without the monotonicity assumption.
    Yang F; Ding P
    Biometrics; 2018 Dec; 74(4):1232-1239. PubMed ID: 29665626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bounds on the average causal effects in randomized trials with noncompliance by covariate adjustment.
    Shan N; Xu PF
    Biom J; 2016 Nov; 58(6):1311-1318. PubMed ID: 27062639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bounds on direct effects in the presence of confounded intermediate variables.
    Cai Z; Kuroki M; Pearl J; Tian J
    Biometrics; 2008 Sep; 64(3):695-701. PubMed ID: 18162106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifiability of causal effects for binary variables with baseline data missing due to death.
    Yan W; Hu Y; Geng Z
    Biometrics; 2012 Mar; 68(1):121-8. PubMed ID: 21838813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sharp bounds on causal effects using a surrogate endpoint.
    Kuroki M
    Stat Med; 2013 Nov; 32(25):4338-47. PubMed ID: 23754776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sharp nonparametric bounds and randomization inference for treatment effects on an ordinal outcome.
    Chiba Y
    Stat Med; 2017 Nov; 36(25):3966-3975. PubMed ID: 28703430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect.
    Shen C; Jeong J; Li X; Chen PS; Buxton A
    Biometrics; 2013 Sep; 69(3):724-31. PubMed ID: 23865447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bounds on causal effects in randomized trials with noncompliance under monotonicity assumptions about covariates.
    Chiba Y
    Stat Med; 2009 Nov; 28(26):3249-59. PubMed ID: 19777494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bounds on potential risks and causal risk differences under assumptions about confounding parameters.
    Chiba Y; Sato T; Greenland S
    Stat Med; 2007 Dec; 26(28):5125-35. PubMed ID: 17525935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of causal effects in the presence of nonignorable missing outcome values.
    Mattei A; Mealli F; Pacini B
    Biometrics; 2014 Jun; 70(2):278-88. PubMed ID: 24447366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large sample bounds on the survivor average causal effect in the presence of a binary covariate with conditionally ignorable treatment assignment.
    Freiman MH; Small DS
    Int J Biostat; 2014; 10(2):143-63. PubMed ID: 25294716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Bounds to Compare the Strength of Exchangeability Assumptions for Internal and External Validity.
    Breskin A; Westreich D; Cole SR; Edwards JK
    Am J Epidemiol; 2019 Jul; 188(7):1355-1360. PubMed ID: 30834430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulating tightest bounds on causal effects in studies with unmeasured confounders.
    Kuroki M; Cai Z
    Stat Med; 2008 Dec; 27(30):6597-611. PubMed ID: 18780415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable selection for clustering with Gaussian mixture models.
    Maugis C; Celeux G; Martin-Magniette ML
    Biometrics; 2009 Sep; 65(3):701-9. PubMed ID: 19210744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal structural models for estimating principal stratum direct effects under the monotonicity assumption.
    Chiba Y
    Biom J; 2011 Nov; 53(6):1025-34. PubMed ID: 22020774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sharp bounds on the relative treatment effect for ordinal outcomes.
    Lu J; Zhang Y; Ding P
    Biometrics; 2020 Jun; 76(2):664-669. PubMed ID: 31742664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.